These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9818754)

  • 41. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
    George J; Morrissey I
    J Antimicrob Chemother; 1997 Jun; 39(6):719-23. PubMed ID: 9222040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
    Ishigo S; Tamaya T; Matsubara S; Suematsu H; Sawamura H; Matsukawa Y; Hashido H; Iwata I; Mikamo H
    Jpn J Antibiot; 2000 Dec; 53(12):652-9. PubMed ID: 11234221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
    Visalli MA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1996 Jan; 37(1):77-84. PubMed ID: 8647777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jan; 35(1):230-2. PubMed ID: 7768776
    [No Abstract]   [Full Text] [Related]  

  • 45. In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae.
    Klugman K; Wasas A
    J Antimicrob Chemother; 1995 Nov; 36(5):873-4. PubMed ID: 8626270
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.
    Mazzulli T; Simor AE; Jaeger R; Fuller S; Low DE
    Antimicrob Agents Chemother; 1990 Mar; 34(3):467-9. PubMed ID: 2334158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Nomura S; Hanaki H; Furukawa T; Unemi N
    Chemotherapy; 1997; 43(1):1-5. PubMed ID: 8996734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates.
    Oncü S; Punar M; Eraksoy H
    Chemotherapy; 2004 Jun; 50(2):98-100. PubMed ID: 15211085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.
    Appelbaum PC; Spangler SK; Crotty E; Jacobs MR
    J Antimicrob Chemother; 1989 Apr; 23(4):509-16. PubMed ID: 2545656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
    Miller D; Alfonso EC
    Cornea; 2004 Apr; 23(3):289-93. PubMed ID: 15084863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.
    Goldsmith CE; Moore JE; Murphy PG; Ambler JE
    J Antimicrob Chemother; 1998 Mar; 41(3):420-1. PubMed ID: 9578174
    [No Abstract]   [Full Text] [Related]  

  • 53. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
    Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
    Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
    J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents.
    Rubio MC; Goñi P; Vergara Y; Seral C; García C; Gómez-Lus P; Gómez-Lus R
    J Chemother; 1999 Jun; 11(3):191-4. PubMed ID: 10435680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.
    Hunt Gerardo S; Citron DM; Claros MC; Goldstein EJ
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2413-5. PubMed ID: 8891154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S; Noviello S; Ianniello F
    J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bactericidal activity of moxifloxacin against pneumococci.
    Levy D; Berche P
    Clin Microbiol Infect; 2001 Jan; 7(1):47-8. PubMed ID: 11284948
    [No Abstract]   [Full Text] [Related]  

  • 59. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1996 May; 25(1):47-51. PubMed ID: 8831045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.